Familial Hypercholesterolemia
- 1 May 2015
- journal article
- review article
- Published by Elsevier BV in Cardiology Clinics
- Vol. 33 (2), 169-179
- https://doi.org/10.1016/j.ccl.2015.01.001
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Living the PCSK9 Adventure: from the Identification of a New Gene in Familial Hypercholesterolemia Towards a Potential New Class of Anticholesterol DrugsCurrent Atherosclerosis Reports, 2014
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis SocietyEuropean Heart Journal, 2013
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 studyThe Lancet, 2012
- Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trialThe Lancet, 2012
- Effect of a Monoclonal Antibody to PCSK9 on LDL CholesterolThe New England Journal of Medicine, 2012
- Redefining Normal Low-Density Lipoprotein Cholesterol: A Strategy to Unseat Coronary Disease as the Nation's Leading KillerJournal of the American College of Cardiology, 2010
- Clinical Utility of Bile Acid Sequestrants in the Treatment of Dyslipidemia: A Scientific ReviewSouthern Medical Journal, 2006
- Efficacy and Safety of Statin Therapy in Children With Familial HypercholesterolemiaJAMA, 2004
- LDL apheresisAtherosclerosis, 2003
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986